NOSTRIN and neoplasm: Patients with established CAD and those with a history of neoplasia showed higher serum Nostrin at AKI onset (36.0 +/-2.9 ng/mL vs. 29.8 +/-2.9 ng/mL, p = 0.014 and 41.8 +/-5.6 ng/mL vs. 28.9 +/-1.8 ng/mL, p = 0.018).